Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin blood pressure effects in elderly Chinese patients with hypertension and type 2 diabetes
ChiCTR2100054678Phase 4Completed
- Sponsor
- Jiangxi Provincial People's Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypertension (HTN) and type 2 diabetes mellitus (T2DM) comparing Empagliflozin with Placebo (2 arms). Primary endpoints: 24-hour mean systolic blood pressure, 24-hour mean diastolic blood pressure and 3 more. Started Jan 2020; status: completed.
02
Drugs
empagliflozin
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2100054678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054678.